ms. reilly, let's begin with you and then hear from each witness. lly: thank you for having me here today. , theyhe past 20 years have approved more than 500 new medicines to market. through innovation, the hiv-aids death rate has dropped 86 preset in this country, from the mid-1990's. progress that has been made in the face of oncology has been heralded drug spending growth is actually declining from its peak in 2014. in fact, last year restriction drugs bending cost rose 3%-5% according to public and i experts in line with all other terms of spending growth. in nonretail and physician 14%nistered drugs remains of what we spend in terms of total health care dollars in this country. when people talk about that 14%, there is a presumption that all of that comes back to the brand name manufacturer. in fact, less than half of that percent, about 6.8 is it what we spend on total health or in this country comes back to the brand name industry. the rest goes to the generic history and others in the supply chain. of the supplypart chain that is not here wi

ms. reilly talked about between brands and generics. it historically has been a carefully balanced ecosystem created by hatch/waxman where we made a decision in the '80s to make the investment for the ability to bring novel therapeutics to market sooner rather than later and ultimately get a utilization rate and lower cost generic costs than the rest of the world. to the question that was asked earlier, why shouldn't we consider importing generics from canada, they're more expensive in canada. >> i bet the idea, and i approve of being able to import. i bet you the idea would be to import the drugs that are cheaper. that's just my guess about what consumers would do. and i almost -- i don't know, i used to be in comedy. i almost think that your answer there was a tad absurd, which is of course, we're not saying we need the right to import the same drug that's more expensive in the other country. do you understand kind of the absurdity of saying that? >> senator, my intention in saying that -- >> i mean -- >> to look at policy and underst